180 related articles for article (PubMed ID: 18928339)
1. Current evidence for aripiprazole as augmentation therapy in major depressive disorder.
Khan A
Expert Rev Neurother; 2008 Oct; 8(10):1435-47. PubMed ID: 18928339
[TBL] [Abstract][Full Text] [Related]
2. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study.
Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R
World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104
[TBL] [Abstract][Full Text] [Related]
3. A review of the safety and tolerability of aripiprazole.
Pae CU
Expert Opin Drug Saf; 2009 May; 8(3):373-86. PubMed ID: 19505266
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.
Chen SJ; Hsiao YL; Shen TW; Chen ST
J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444
[TBL] [Abstract][Full Text] [Related]
6. The effects of aripiprazole on the subscales of the Kellner Symptom Questionnaire in treatment resistant depression.
Dording C; Cassiello C; King F; Pencina M; Fava M; Mischoulon D
Int Clin Psychopharmacol; 2013 Sep; 28(5):238-44. PubMed ID: 23764521
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole augmentation for major depressive disorder: dosing patterns in a naturalistic treatment setting.
Pae CU; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS
Int Clin Psychopharmacol; 2014 Mar; 29(2):116-9. PubMed ID: 24108149
[TBL] [Abstract][Full Text] [Related]
8. Neurobiological bases and clinical aspects of the use of aripiprazole in treatment-resistant major depressive disorder.
Blier P; Blondeau C
J Affect Disord; 2011 Jan; 128 Suppl 1():S3-10. PubMed ID: 21220079
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
11. Role of aripiprazole in treating mood disorders.
García-Amador M; Pacchiarotti I; Valentí M; Sanchez RF; Goikolea JM; Vieta E
Expert Rev Neurother; 2006 Dec; 6(12):1777-83. PubMed ID: 17181424
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Boulton DW; Balch AH; Royzman K; Patel CG; Berman RM; Mallikaarjun S; Reeves RA
J Psychopharmacol; 2010 Apr; 24(4):537-46. PubMed ID: 18832427
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data.
Pae CU; Forbes A; Patkar AA
CNS Drugs; 2011 Feb; 25(2):109-27. PubMed ID: 21254788
[TBL] [Abstract][Full Text] [Related]
15. Global benefit-risk analysis of adjunctive aripiprazole in the treatment of patients with major depressive disorder.
Wisniewski SR; Chen CC; Kim E; Kan HJ; Guo Z; Carlson BX; Tran QV; Pikalov A
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):965-72. PubMed ID: 19662630
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.
Arbaizar B; Dierssen-Sotos T; Gómez-Acebo I; Llorca J
Gen Hosp Psychiatry; 2009; 31(5):478-83. PubMed ID: 19703642
[TBL] [Abstract][Full Text] [Related]
17. Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.
Weisler RH; Khan A; Trivedi MH; Yang H; Eudicone JM; Pikalov A; Tran QV; Berman RM; Carlson BX
J Clin Psychiatry; 2011 Apr; 72(4):548-55. PubMed ID: 20816039
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy.
Nelson JC; Thase ME; Bellocchio EE; Rollin LM; Eudicone JM; McQuade RD; Marcus RN; Berman RM; Baker RA
Int Clin Psychopharmacol; 2012 May; 27(3):125-33. PubMed ID: 22466058
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial.
Mischoulon D; Witte J; Levy M; Papakostas GI; Pet LR; Hsieh WH; Pencina MJ; Ward S; Pollack MH; Fava M
J Clin Psychiatry; 2012 Mar; 73(3):353-7. PubMed ID: 21939613
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients.
Coley KC; Scipio TM; Ruby C; Lenze EJ; Fabian TJ
J Psychiatr Pract; 2009 Mar; 15(2):150-3. PubMed ID: 19339850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
